Full Text View
Tabular View
No Study Results Posted
Related Studies
Lipid Efficacy/Tolerability Study
This study has been completed.
Study NCT00269204   Information provided by Merck

First Received on December 21, 2005.   Last Updated on May 12, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Primary Hypercholesterolaemia
Mixed Hyperlipidaemia
Additional conditions recognized in this trial
Hypercholesterolemia
Hyperlipidemia, Familial Combined
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Genetic Diseases, Inborn
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Metabolic Diseases
Metabolism, Inborn Errors
Interventions listed in this trial
niacin (+) laropiprant
ER-niacin
Additional drug interventions recognized in this trial
Niacin
More general drug interventions related to this trial
Antimetabolites
Cardiovascular Agents
Growth Substances
Hypolipidemic Agents
Lipid Regulating Agents
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Vasodilator Agents
Vitamin B Complex
Vitamins
Sponsors listed in this trial
Merck


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services